Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 59

1.

Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis.

Zochling J, van der Heijde D, Dougados M, Braun J.

Ann Rheum Dis. 2006 Apr;65(4):423-32. Epub 2005 Aug 26. Review.

PMID:
16126792
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

First update of the current evidence for the management of ankylosing spondylitis with non-pharmacological treatment and non-biologic drugs: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis.

van den Berg R, Baraliakos X, Braun J, van der Heijde D.

Rheumatology (Oxford). 2012 Aug;51(8):1388-96. doi: 10.1093/rheumatology/kes066. Epub 2012 Apr 17. Review.

PMID:
22513148
[PubMed - indexed for MEDLINE]
Free Article
3.

Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.

McLeod C, Bagust A, Boland A, Dagenais P, Dickson R, Dundar Y, Hill RA, Jones A, Mujica Mota R, Walley T.

Health Technol Assess. 2007 Aug;11(28):1-158, iii-iv. Review.

PMID:
17651658
[PubMed - indexed for MEDLINE]
Free Article
4.

Nonsurgical management of ankylosing spondylitis.

Sangala JR, Dakwar E, Uribe J, Vale F.

Neurosurg Focus. 2008;24(1):E5. doi: 10.3171/FOC/2008/24/1/E5. Review.

PMID:
18290743
[PubMed - indexed for MEDLINE]
5.

EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Zhang W, Doherty M, Arden N, Bannwarth B, Bijlsma J, Gunther KP, Hauselmann HJ, Herrero-Beaumont G, Jordan K, Kaklamanis P, Leeb B, Lequesne M, Lohmander S, Mazieres B, Martin-Mola E, Pavelka K, Pendleton A, Punzi L, Swoboda B, Varatojo R, Verbruggen G, Zimmermann-Gorska I, Dougados M; EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Ann Rheum Dis. 2005 May;64(5):669-81. Epub 2004 Oct 7. Review.

PMID:
15471891
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

A systematic literature review of drug therapies for the treatment of psoriatic arthritis: current evidence and meta-analysis informing the EULAR recommendations for the management of psoriatic arthritis.

Ash Z, Gaujoux-Viala C, Gossec L, Hensor EM, FitzGerald O, Winthrop K, van der Heijde D, Emery P, Smolen JS, Marzo-Ortega H.

Ann Rheum Dis. 2012 Mar;71(3):319-26. doi: 10.1136/ard.2011.150995. Epub 2011 Jul 28. Review.

PMID:
21803753
[PubMed - indexed for MEDLINE]
7.

Cost effectiveness of therapeutic interventions in ankylosing spondylitis: a critical and systematic review.

Gaujoux-Viala C, Fautrel B.

Pharmacoeconomics. 2012 Dec 1;30(12):1145-56. doi: 10.2165/11596490-000000000-00000. Review.

PMID:
23098324
[PubMed - indexed for MEDLINE]
8.

2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis.

Braun J, van den Berg R, Baraliakos X, Boehm H, Burgos-Vargas R, Collantes-Estevez E, Dagfinrud H, Dijkmans B, Dougados M, Emery P, Geher P, Hammoudeh M, Inman RD, Jongkees M, Khan MA, Kiltz U, Kvien T, Leirisalo-Repo M, Maksymowych WP, Olivieri I, Pavelka K, Sieper J, Stanislawska-Biernat E, Wendling D, Ozgocmen S, van Drogen C, van Royen B, van der Heijde D.

Ann Rheum Dis. 2011 Jun;70(6):896-904. doi: 10.1136/ard.2011.151027.

PMID:
21540199
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Medical management of ankylosing spondylitis.

Khalessi AA, Oh BC, Wang MY.

Neurosurg Focus. 2008;24(1):E4. doi: 10.3171/FOC/2008/24/1/E4. Review.

PMID:
18290742
[PubMed - indexed for MEDLINE]
10.

First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis.

Braun J, Davis J, Dougados M, Sieper J, van der Linden S, van der Heijde D; ASAS Working Group.

Ann Rheum Dis. 2006 Mar;65(3):316-20. Epub 2005 Aug 11.

PMID:
16096329
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines.

Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P.

Osteoarthritis Cartilage. 2008 Feb;16(2):137-62. doi: 10.1016/j.joca.2007.12.013. Review.

PMID:
18279766
[PubMed - indexed for MEDLINE]
Free Article
12.

Update of the literature review on treatment with biologics as a basis for the first update of the ASAS/EULAR management recommendations of ankylosing spondylitis.

Baraliakos X, van den Berg R, Braun J, van der Heijde D.

Rheumatology (Oxford). 2012 Aug;51(8):1378-87. doi: 10.1093/rheumatology/kes026. Epub 2012 Mar 16. Review.

PMID:
22427410
[PubMed - indexed for MEDLINE]
Free Article
13.

A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn's disease.

Dretzke J, Edlin R, Round J, Connock M, Hulme C, Czeczot J, Fry-Smith A, McCabe C, Meads C.

Health Technol Assess. 2011 Feb;15(6):1-244. doi: 10.3310/hta15060. Review.

PMID:
21291629
[PubMed - indexed for MEDLINE]
Free Article
14.

Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.

Woolacott N, Bravo Vergel Y, Hawkins N, Kainth A, Khadjesari Z, Misso K, Light K, Asseburg C, Palmer S, Claxton K, Bruce I, Sculpher M, Riemsma R.

Health Technol Assess. 2006 Sep;10(31):iii-iv, xiii-xvi, 1-239. Review.

PMID:
16948890
[PubMed - indexed for MEDLINE]
Free Article
15.

Safety and efficacy of on-demand versus continuous use of nonsteroidal antiinflammatory drugs in patients with inflammatory arthritis: a systematic literature review.

Adams K, Bombardier C, van der Heijde D.

J Rheumatol Suppl. 2012 Sep;90:56-8. doi: 10.3899/jrheum.120343. Review.

PMID:
22942330
[PubMed - indexed for MEDLINE]
16.

[The role of biologic agents in the therapy of ankylosing spondylitis].

Géher P, Nagy MB, Péntek M, Tóth E, Brodszky V, Gulácsi L.

Orv Hetil. 2006 Jul 2;147(26):1203-13. Review. Hungarian.

PMID:
16898082
[PubMed - indexed for MEDLINE]
17.

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.

Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK, McInnes IB, Haentzschel H, Gonzalez-Gay MA, Provan S, Semb A, Sidiropoulos P, Kitas G, Smulders YM, Soubrier M, Szekanecz Z, Sattar N, Nurmohamed MT.

Ann Rheum Dis. 2010 Feb;69(2):325-31. doi: 10.1136/ard.2009.113696. Epub 2009 Sep 22.

PMID:
19773290
[PubMed - indexed for MEDLINE]
18.

Conventional treatments for ankylosing spondylitis.

Dougados M, Dijkmans B, Khan M, Maksymowych W, van der Linden S, Brandt J.

Ann Rheum Dis. 2002 Dec;61 Suppl 3:iii40-50. Review.

PMID:
12381510
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologists.

Sidiropoulos PI, Hatemi G, Song IH, Avouac J, Collantes E, Hamuryudan V, Herold M, Kvien TK, Mielants H, Mendoza JM, Olivieri I, Østergaard M, Schachna L, Sieper J, Boumpas DT, Dougados M.

Rheumatology (Oxford). 2008 Mar;47(3):355-61. doi: 10.1093/rheumatology/kem348. Review.

PMID:
18276738
[PubMed - indexed for MEDLINE]
Free Article
20.

The treatment of ankylosing spondylitis.

Scalapino KJ, Davis JC Jr.

Clin Exp Med. 2003 Feb;2(4):159-65. Review.

PMID:
12624705
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk